Study to examine effectiveness of using video calls to deliver care for people with Parkinson's disease

NewsGuard 100/100 Score

People living with Parkinson's disease today often face challenges when seeking care, including disability, distance from medical centers, and distribution of doctors. In fact, 42 percent of those diagnosed with Parkinson's disease, and more living with the condition, do not see a neurologist for their care. Now, a national study will attempt to disrupt the status quo and bring expert Parkinson's care directly into patients' homes using video visit technology.

"The idea that we can provide care to individuals with Parkinson's disease regardless of where they live is both a simple and revolutionary concept," according to University of Rochester neurologist and study author Ray Dorsey, MD.

The Connect.Parkinson study, with support from the National Parkinson Foundation (NPF) and the Patient Centered Outcomes Research Institute, will enroll some 200 people with Parkinson's disease this year and use simple, secure web-based videoconferencing software by SBR Health to examine the effectiveness and feasibility of using video calls to deliver care into the homes of people with Parkinson's disease. 

Neurologists participating in the study will use the same video technology in place at some of today's top healthcare organizations, including Partners Healthcare, Mayo Clinic, Joslin Diabetes and others, to connect to patients from a computer, tablet and or smartphone to assess their condition and develop a treatment plan.

"Technology has been slow to infiltrate medicine and, when it has, it mostly has been supporting a model of care developed in the 1800's, which remains essentially unchanged. For the first time, we are looking at redesigning care from first principals," said Peter Schmidt, PhD, NPF's Vice President, Research and Professional Programs. "We are looking at the best way to help people using all the resources we now have at our disposal."

SBR Health (www.sbrhealth.com), an innovative health technology company that provides video visit solutions that enable the creation of virtual health delivery networks for chronic conditions like Parkinson's disease, Alzheimer's disease, diabetes, congestive heart failure and more, will provide the technology platform for this study.

"Instead of the patient having to travel to the provider, we're bringing the provider to the patient, which for patients with chronic illnesses who may have difficulty traveling and or are far from specialty care, we're changing the care delivery paradigm and making care push-button simple with video technology," said Christopher Herot, Chief Executive Officer of SBR Health.

As chronic conditions affect an estimated 140 million Americans and account for more than 75 percent of healthcare spending today, the goal of the study is to demonstrate the effectiveness of using video technology in care for patients. Once scaled, this effort could bring together the country's leading healthcare organizations and potentially transform care in unprecedented ways, while improving patients' health and overall quality of life.

"This research seeks to demonstrate that we can reach anyone, anywhere with a given condition," said Dorsey. "If we can successfully remove the barriers to telemedicine, this approach will ultimately allow more patients with Parkinson's disease to live independently in their homes, while still getting the care they need."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Landmark study confirms five key Parkinson's Disease variants in largest meta-analysis